TABLE 7.
Summary of results for 23 immunocompromised patients with current CMV infection (group C)
| EBV antibody pattern compatibility | No. determined by:
|
|||||
|---|---|---|---|---|---|---|
| Captia (VCA IgM/IgG/ EBNA IgG) | Enzygnost (IgM/IgG) | Vironostika (VCA IgM/IgG/ EBNA IgG) | Virion (VCA IgM/IgG/ EBNA IgG) | Biotest (EA IgM/IgG/ EBNA IgG) | Gull (VCA IgM/IgG/ EBNA IgG) | |
| Previous infection (−/+/+ or −/−/+) | 19 | 21 | 15 | 17 | 19 | 21 |
| EBV reactivation (+/+/+ or +/−/+) | 1 | 2 | ||||
| Seronegative patient (−/−/−) | 1 | 1 | 1 | 1 | 1 | 1 |
| EBNA IgG negative, antibody pattern consistent with primary infection (+/+/−, +/−/−, or −/+/−) | 2 | 5 | 4 | |||
| Inconclusive resulta | 1 | 1 | 1 | 1 | 1 | 1 |
a
Excluded from the specificity calculation.